Maze Therapeutics Inc

The current institutional shareholding score of Maze Therapeutics Inc is 10.00, ranking 1 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 97.33%, representing a quarter-over-quarter increase of 14.80%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.03% of shares outstanding, with 5.26% increase in holdings.